Press release
Metabolomics Market Worth $5.33 Billion by 2028 - Arizton
Metabolomics Market Research Report by Arizton
To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3859
Browse In-Depth TOC on Metabolomics Market
134 - Tables
119 - Charts
305 - Pages
Metabolomics is a rapidly growing field of research that revolutionizes understanding of food safety and quality control. Analyzing metabolites in food makes it possible to detect potential contaminants, determine the nutritional quality of food, and identify and quantify the flavor and aroma compounds in food. This knowledge is essential for food safety and quality control professionals and consumers and will continue to be a valuable tool. Increased funding for metabolomics research is essential to realize its full potential. This research can revolutionize our understanding of the human body and its biochemical processes. It could lead to new disease treatments and improved diagnosis and prevention methods. Therefore, the necessary investments must be made in metabolomics research to realize this field's potential.
Customize Your Report Now:
If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3859
North America to Contribute Larger Share in the Metabolomics Market
In 2022, North America accounted for the global metabolomics market's highest revenue share, 40.37%. The surge in the adoption of personalized medicine due to the rise in chronic diseases, such as cardiovascular diseases, and the high mortality rate associated with genetic diseases are expected to drive market growth. The increase in R&D expenditure on initiatives for applications of metabolomics in personalized medicine and the rise in the number of instruments and reagents for proteomic research will also drive growth across North America.
The leading causes of death and disability contribute to $3.8 trillion in annual healthcare costs in the US. Every six in 10 adults in the country have a chronic disease, and four in 10 adults have two or more chronic diseases. The leading causes of mortality in the country include heart disease, cancer, chronic lung disease, stroke, Alzheimer's disease, diabetes, and chronic kidney disease. The surge in the prevalence of chronic diseases has encouraged the country to shift its focus to adopting personalized medicine. The high R&D investments in metabolomics for biomarker discoveries and the development of personalized medicine in oncology due to the rise in the prevalence of cancer and other genetic diseases are expected to drive the growth of the US market. Companies such as Bruker, Life Technologies, Waters, and Thermo Fisher Scientific, provide various products, including diagnostic instruments, software, reagents, and kits for metabolomics research. Several US independent research groups and universities are also involved in metabolomics research.
Buy the Report Now: https://www.arizton.com/market-reports/metabolomics-market
Post-Purchase Benefit
1hr of free analyst discussion
10% of customization
The global metabolomics market is highly competitive and consists of several key players. Agilent Technologies, Bio-Rad Laboratories, Thermo-Fisher Scientific, Danaher, and PerkinElmer are major players that offer metabolomics products. The key global players focus on developing innovative technologies or methods and expanding their product portfolio through acquisitions to remain competitive. Most players continuously invest extensively in R&D and product development initiatives to expand their product portfolio and ensure a sustainable presence in the highly competitive environment. However, Vendors focus on developing and commercializing metabolomics instruments, reagents, consumables, and software to remain competitive and gain a significant presence in the market. New product approvals coupled with R&D activities help vendors to expand their presence, enhance market growth, and sustain their position in the global market. Vendors actively develop innovative metabolomics technologies to tap the tremendous growth potential in the market.
Key Company Profiles
Agilent Technologies
Bio-Rad Laboratories
Danaher
PerkinElmer
Thermo Fisher Scientific
Advion
BGI
biocrates life sciences
Bruker
LECO
Merck KGaA
SCION Instruments
Shimadzu Corporation
Waters
Metabolomics Service Providers
Creative Proteomics
Human Metabolome Technologies
Metabolon
Metaware Biotechnology
MS-OMICS
VProteomics
Market Segmentation
Technologies: Detection Methods, Separation Methods, and Bioinformatics Tools & Services
Application: Medical & Clinical Research, Plant & Food Science, and Biotechnology
End-user: Standalone Metabolomic Service Providers, Pharma & Biotech Companies, Research & Clinical Laboratories, and Others
Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Key Questions Answered in the Report:
How big is the metabolomics market?
What is the growth rate of the metabolomics market?
What are the rising trends in the metabolomics market?
Which region holds the most significant global metabolomics market share?
Who are the key players in the global metabolomics market?
Get Detailed TOC @ https://www.arizton.com/market-reports/metabolomics-market
Why Arizton?
100% Customer Satisfaction
24x7 availability - we are always there when you need us
200+ Fortune 500 Companies trust Arizton's report
80% of our reports are exclusive and first in the industry
100% more data and analysis
1500+ reports published till date
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Contact Us
Call: +1-312-235-2040
+1 302 469 0707
Mail: enquiry@arizton.com
Contact Us: https://www.arizton.com/contact-us
Blog: https://www.arizton.com/blog
Website: https://www.arizton.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metabolomics Market Worth $5.33 Billion by 2028 - Arizton here
News-ID: 3252941 • Views: …
More Releases for Metabolomic
Metabolomic Platform Market A Comprehensive Study by Leading Key Players: Agilen …
HTF Market Insights just released the Global Metabolomic Platform Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies Metabolomic Platform Market are:
Agilent Technologies, Thermo Fisher…
Metabolomics Biomarker Market Growth in Future Scope 2024-2031 | BG Medicine Inc …
New Research report, titled "Metabolomics Biomarker Market" Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the worldwide market. The Metabolomics Biomarker market has been growing significantly in recent years, driven by a number of key factors, such as increasing…
Metabolomics Services Market Overall Study Report 2024-2031 | Thermo Fisher Scie …
𝐑𝐞𝐩𝐨𝐫𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Coherent Market Insights announces the release of a new report titled Metabolomics Services Market: By Size, Trends, Share, Growth, Segments, Industry Analysis and Forecast, 2031. The research report conducts an in-depth market study to provide a comprehensive analysis of the current state and future potential of the Metabolomics Services Market. It covers several aspects, including industry size, key players, growth drivers, key opportunities, and challenges. Besides, market segmentation, competitive…
Preeclampsia Diagnostics Market size, share, demand and Opportunities Analysis b …
Preeclampsia is a disorder that can occur during pregnancy or after childbirth. It is characterized by high blood pressure and protein in the urine. Preeclampsia can be mild or severe. In severe cases, it can lead to eclampsia, which is a potentially life-threatening condition. Preeclampsia is diagnosed by measuring blood pressure and testing for protein in the urine. Treatment typically involves taking medications to lower blood pressure and monitoring the…
Breast Cancer Screening Market research report features players tapping emerging …
Newark, New Castle, USA: According to the deep-dive market assessment study conducted by Growth Plus Reports, the global Breast Cancer Screening market was pegged at US$ 2.50 billion in 2021. The market is expected to witness a CAGR of 6.7% from 2022 to 2030. The research report investigates the BioTime Inc., Siemens Healthcare Diagnostics Inc., A&G Pharmaceutical Inc., POC Medical Systems Inc., Biocrates Life Sciences AG
The global Breast Cancer Screening…
Metabolomic Platform Market Research Outlook: 2022, Growth Estimation, New Techn …
The "Metabolomic Platform Market" Research Report is an intelligence report that has been meticulously compiled to research relevant and valuable information. The data studied is designed with both the best existing players and future competitors in mind. The key player's business strategy and new market industries are studied in detail. The report makes future forecasts based on an analysis of market segmentation, including product categories, end-user applications, and global Metabolomic…
